Arrayit has increased the speed with which it makes microarrays, tiny glass substrates that contain rows and columns of printed spots and used for scientific research and molecular diagnostics.
The advance allows precise printing of as many as 2.4 million microarrays per year with a single robotic workstation, a significant increase over the company's current capacity of 640,000 microarrays a year per instrument.
Arrayit is currently developing early-stage definitive diagnostic tests for ovarian cancer, Parkinson's disease, H1N1 and other illnesses.
